Congress trades
SpringWorks Therapeutics, Inc. (SWTX)
About SpringWorks Therapeutics, Inc.
from the company's filings and listing- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Chief executive
- Saqib Islam
- Employees
- 368
- Listed since
- -
- Market value
- $3.5B
- Price to earnings
- -
- Earnings per share
- -$3.48
- Dividend yield
- -
Earnings
6 reported quarters| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Aug 6, 2025 | -$0.54 | -$0.81 | n/a | $73.4M | EPS beatRevenue n/a |
| Q1 FY2025reported May 9, 2025 | -$1.11 | -$0.81 | $49.1M | $67.0M | EPS missRevenue miss |
| Q4 FY2024reported Feb 20, 2025 | -$1.04 | -$0.72 | $61.5M | $66.7M | EPS missRevenue miss |
| Q3 FY2024reported Nov 12, 2024 | -$0.72 | -$0.76 | $49.3M | $57.1M | EPS beatRevenue miss |
| Q2 FY2024reported Aug 7, 2024 | -$0.54 | -$1.12 | $59.7M | $34.3M | EPS beatRevenue beat |
| Q1 FY2024reported May 2, 2024 | -$1.18 | -$1.17 | $21.0M | $12.2M | EPS in lineRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2024 · proxy filed Apr 4, 2025| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Saqib Islam, J.D.Chief Executive Officer | $760K | $7.9M | $7.5M | $16.2M |
| Badreddin Edris, Ph.D.Chief Operating Officer | $620K | $1.6M | $3.7M | $5.9M |
| James Cassidy, M.D., Ph.D.Chief Medical Officer | $525K | $1.1M | $2.5M | $4.1M |
| Bhavesh Ashar, M.B.A.Chief Commercial Officer | $525K | $1.0M | $2.3M | $3.9M |
| Francis I. PerierJr., M.B.A., Chief Financial Officer | $510K | $812K | $1.9M | $3.2M |
The summary compensation table from the 2024 proxy statement, current executives only. Read the filing
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in SWTX
6 disclosures of 6 on record · median 27d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | n/a | Jul 2, 2025 | Aug 11, 2025 | 40d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $15,001 - $50,000 | n/a | Jul 1, 2025 | Jul 10, 2025 | 9d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | +28.7%S&P +2.6% · vs S&P 500 +26.0% | Jan 29, 2025 | Feb 11, 2025 | 13d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +24.6%S&P +12.6% · vs S&P 500 +12.0% | Jul 19, 2024 | Aug 15, 2024 | 27d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +29.8%S&P +12.6% · vs S&P 500 +17.1% | Jun 18, 2024 | Jul 9, 2024 | 21d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +9.4%S&P +18.8% · vs S&P 500 -9.4% | May 9, 2024 | Jun 8, 2024 | 30d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 6, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Questions
Which members of Congress have traded SWTX?
Josh Gottheimer, Gilbert Ray Cisneros, Jr. disclosed SWTX transactions in the filings shown here.
How quickly are SWTX trades disclosed?
Congressional disclosures took a median of 27 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.